Post

FDA generic drug approvals rose in 2023 in bid for improved access

The US Food and Drug Administration (FDA) Office of Generic Drugs has reported improvements in the number of generic drugs …

CHMP provides positive opinion for BMS’s Reblozyl

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has provided a positive opinion for the approval …

FDA to decide on Sanofi/Regeneron’s Dupixent for COPD in June

Sanofi and Regeneron are close to adding chronic obstructive pulmonary disease (COPD) as the sixth indication for its blockbuster therapy …

Anticipation rises for RSV rollout as positive data emerges

After record-high levels of respiratory syncytial virus (RSV) were seen in several countries, the pharmaceutical landscape for RSV infections has …

Bavarian Nordic’s chikungunya vaccine secures EMA fast-track

Hot on the heels of dropping its cancer vaccine programme, Bavarian Nordic has secured a win in more familiar territory, …